Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash & Current Investments came in at $15.0 million in Q4 2025, down 81.06% year-over-year from $79.4 million in Q4 2024, and down 36.44% quarter-over-quarter from $23.7 million in Q3 2025.
Analysis
Vicarious Surgical (RBOT) Cash & Current Investments (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash & Current Investments for 6 consecutive years, with $15.0 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 81.06% year-over-year to $15.0 million in Q4 2025; TTM through Dec 2025 was $15.0 million, a 81.06% decrease from a year earlier, with the FY2025 full-year figure at $15.0 million, down 81.06% from the prior year.
- Cash & Current Investments was $15.0 million for Q4 2025 at Vicarious Surgical, down from $23.7 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $186.0 million in Q3 2023 and troughed at $1.0 million in Q1 2021.
- A 5-year average of $98.3 million and a median of $107.3 million in 2023 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments jumped 15173.98% in 2022 and plunged 81.06% in 2025, its largest moves.
- Over 5 years, Cash & Current Investments stood at $173.5 million in 2021, then sank by 33.02% to $116.2 million in 2022, then rose by 5.16% to $122.2 million in 2023, then slumped by 35.0% to $79.4 million in 2024, then sank by 81.06% to $15.0 million in 2025.
- The last three Cash & Current Investments figures came in at $15.0 million (Q4 2025), $23.7 million (Q3 2025), and $44.0 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | 15.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15.04 Mn |
| Sep 30, 2025 | 23.66 Mn |
| Jun 30, 2025 | 44.02 Mn |
| Mar 31, 2025 | 72.13 Mn |
| Dec 31, 2024 | 79.43 Mn |
| Sep 30, 2024 | 114.66 Mn |
| Jun 30, 2024 | 73.23 Mn |
| Mar 31, 2024 | 130.03 Mn |
| Dec 31, 2023 | 122.20 Mn |
| Sep 30, 2023 | 185.99 Mn |
| Jun 30, 2023 | 99.95 Mn |
| Mar 31, 2023 | 97.57 Mn |
| Dec 31, 2022 | 116.21 Mn |
| Sep 30, 2022 | 126.80 Mn |
| Jun 30, 2022 | 141.32 Mn |
| Mar 31, 2022 | 157.01 Mn |
| Dec 31, 2021 | 173.51 Mn |
| Sep 30, 2021 | 185.05 Mn |
| Jun 30, 2021 | 7.71 Mn |
| Mar 31, 2021 | 1.03 Mn |